PRSS1 and pancreatic neoplasm: To assess whether the PRSS1_R116C mutation itself enhances malignant behaviors in pancreatic cancer or triggers the latter by increasing trypsin levels, we constructed stable PANC-1 cell lines with overexpression of PRSS1_R116C (R116C) or wildtype PRSS1 (OE).